Variables, n (%) | Vildagliptin (n = 166) | Sitagliptin (n = 165) | Linagliptin (n = 164) | χ2 values | P values |
---|---|---|---|---|---|
Hypoglycemia | 20 (12.05) | 17 (10.30) | 13 (7.29) | 1.554 | 0.460 |
Gastrointestinal adverse events | 24 (14.46) | 19 (11.52) | 15 (9.15) | 2.260 | 0.323 |
Renal and hepatic toxicity | 6 (3.61) | 5 (3.30) | 2 (1.22) | 2.008 | 0.366 |
Infections | 10 (6.02) | 8 (4.85) | 12 (7.32) | 0.881 | 0.644 |
Chest discomfort | 8 (4.82) | 11 (6.70) | 11 (6.71) | 0.676 | 0.713 |